Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-036018

General Counsel sold 2,358 shares at $8.91 ($21,018)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Miller Edward General Counsel 2022-11-14 Sale −2,358 $8.91 $21,018 190,453 I: show line 1 in the form
Open-market sales · 2,358 sh · avg $8.91 · $21,018
Loading xslF345X03/doc4.xml…